Indication
Cholangiocarcinoma Recurrent
2 clinical trials
6 products
Product
cyclophosphamideClinical trial
A Phase 1/2 Single Arm Open-Label Clinical Trial of Gavocabtagene Autoleucel (Gavo-cel) in Patients With Advanced Mesothelin-Expressing CancerStatus: Active (not recruiting), Estimated PCD: 2028-11-02
Product
IpilimumabProduct
NivolumabProduct
gavo-celProduct
fludarabineProduct
SynKIR-110Clinical trial
A Phase 1 Study of SynKIR-110, Autologous T Cells Transduced With Mesothelin KIR-CAR, in Subjects With Mesothelin-Expressing Advanced Ovarian Cancer, Cholangiocarcinoma, or MesotheliomaStatus: Recruiting, Estimated PCD: 2026-03-15